Call us today: +44 (0) 20 3551 6634
International healthcare researchers have made a breakthrough in the treatment of malaria, discovering a compound that combats the disease at multiple stages in its lifecycle.
The aminopyridine substance, which has been named MMV390048, could potentially be an element of a single-dose cure for malaria and may even be able to prevent the disease from spreading among people.
Scientists at Australia's Griffith University initially identified the aminopyridine series, but its anti-malaria properties were explored and scrutinised by researchers at the University of Cape Town's Drug Discovery and Development Centre in South Africa.
Lead researcher Professor Kelly Chibale, who directs and leads the establishment, argued that the discovery marks a "proud day for African science and African scientists".
The research team is "very excited" about the compound's potential and hopes that when investigations are completed, the drug is found to be an "extremely effective medicine for malaria", she said.
According to research in the Lancet, 24 per cent of all child deaths in sub-Saharan Africa are caused by malaria, while the US' Centre for Disease Control found that approximately 216 million cases of the disease occurred internationally during 2010.
Overall, around 655,000 of these sufferers died and 91 per cent of these fatalities were in Africa.
The disease, which is carried by the Anopheles mosquito, occurs in subtropical and tropical regions, including in south Asia and South America.
Expatriates relocating abroad to a number of tropical countries therefore ought to take out international medical insurance to help them to deal with the risk posed by malaria.
"Clearly the war on this disease is not yet won, but I am excited by the role that our excellent scientists have played in this milestone in finding a potential cure for malaria and possibly preventing its transmission," South African minister of science and technology Naledi Pandor stated.
"Congratulations to Professor Kelly Chibale and all involved," she added.
Expatriate Healthcare specialise in providing international health insurance. Make sure you're protected. © Expatriate Healthcare
Expatriate Group.Delmon House,36-38 Church Road,Burgess Hill,West Sussex,RH15 9AE
Registered Address.35 Ballards Lane,London,N3 1XW
Tel: +44 (0)20 3551 6634Fax: +44 (0)870 428 5141Email: email@example.com
Short Term Healthcare Insurance
Travel Medical Insurance One Way Travel Insurance Single Trip Travel Insurance Annual Multi-Trip Travel Insurance Non UK Resident Travel Insurance Business Travel Insurance
About Us Useful Links Leave a Review Our Awards The Press Room Satisfaction Survey Downloads Legal Notice Underwriters Hospital List
Emergency Assistance information Short-Term Healthcare Working Abroad Insurance Thailand Health Insurance
Register as an Intermediary Opportunities for Brokers
Expatriate Group & Expatriate Healthcare are trading styles of Strategic Insurance Services Limited who is authorised and regulated by the Financial Conduct Authority (FCA). FCA Firm reference Number is 307133. Strategic Insurance Services Limited is authorised to carry on Regulated Activities in accordance with the permissions granted by the FCA under PART IV of the Financial Services and Markets ACT 2000.